KV's Makena rollercoaster descends with FDA compounding OK; J&J tallies another recall, expansion;

> For now, compounding pharmacies will face no regulatory action for producing cheap versions of KV Pharma's just-approved and high-priced pre-term birth drug, Makena. Story

> Add a one-lot recall of Tylenol 8-Hour caplets to J&J/McNeil's ongoing callback parade; add 718,000 caplets of five other drugs to a previous recall. Story

> The FDA has issued an advisory to drugmakers on the formation of glass Lamellae in Injectables. Advisory

> CMO Almac has invested in two ZED automated inline wallet presses, for plants in Pennsylvania and Craigvon, to speed blister card packing. Story

> Unilife has begun initial production of the Unifill ready-to-fill (prefilled) syringe at its plant in York, PA. Release

> Contract manufacturer Pharma Tech Industries has completed a cleanroom for pouch filling of powder-based products, built to house an Oystar Jones Adjustable Pouch King high-speed unit for packaging and sealing technology. Story

> Contractor AAIPharma has relocated its compendial raw materials testing group to a purpose-built lab at company headquarters in Wilmington, NC, headquarters facility. Release

> Unilife Corp. has begun initial production of the Unifill ready-to-fill syringe at its York, PA, facility. Release

Suggested Articles

Fujifilm Diosynth Biotechnologies last year committed 10 billion yen toward its manufacturing operations. It has now kicked off one of those projects.

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.